Paper41358882
8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*. Diabetes Care, 2026. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes-2026. Papers, record 41358882. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41358882
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes-2026.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Obesity | Major topic |
| Diabetes Mellitus | Major topic |
| Standard of Care | Major topic |
| Humans |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07835360 | Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes | Background |
Source ClinicalTrials.gov
References178
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35533384 | Diabetes Screening by Race and Ethnicity in the United States: Equivalent Body Mass Index and Age Thresholds. | Ann Intern Med | 2022 | https://conductscience.org/library/papers/35533384 | PubMed |
| 2 | 28388637 | Unintentional weight loss: Clinical characteristics and outcomes in a prospective cohort of 2677 patients. | PLoS One | 2017 | https://conductscience.org/library/papers/28388637 | PubMed |
| 3 | 14726171 | Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. | Lancet | 2004 | https://conductscience.org/library/papers/14726171 | PubMed |
| 4 | 37385275 | Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. | Lancet | 2023 | https://conductscience.org/library/papers/37385275 | PubMed |
| 5 | 24915261 | Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. | JAMA | 2014 | https://conductscience.org/library/papers/24915261 | PubMed |
| 6 | 34170647 | Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34170647 | PubMed |
| 7 | 26201412 | Lap band outcomes from 19,221 patients across centers and over a decade within the state of New York. | Surg Endosc | 2016 | https://conductscience.org/library/papers/26201412 | PubMed |
| 8 | 23560285 | Substance use following bariatric weight loss surgery. | JAMA Surg | 2013 | https://conductscience.org/library/papers/23560285 | PubMed |
| 9 | 9702435 | Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. | Diabetes Care | 1998 | https://conductscience.org/library/papers/9702435 | PubMed |
| 10 | 36280539 | 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. | Surg Obes Relat Dis | 2022 | https://conductscience.org/library/papers/36280539 | PubMed |
| 11 | 35196654 | Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement. | Obes Facts | 2022 | https://conductscience.org/library/papers/35196654 | PubMed |
| 12 | 25547054 | Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2. | Surg Obes Relat Dis | 2015 | https://conductscience.org/library/papers/25547054 | PubMed |
| 13 | 21481449 | Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. | Lancet | 2011 | https://conductscience.org/library/papers/21481449 | PubMed |
| 14 | 32896055 | What exercise prescription is optimal to improve body composition and cardiorespiratory fitness in adults living with obesity? A network meta-analysis. | Obes Rev | 2021 | https://conductscience.org/library/papers/32896055 | PubMed |
| 15 | 27328752 | The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy. | Int J Obes (Lond) | 2016 | https://conductscience.org/library/papers/27328752 | PubMed |
| 16 | 37700013 | Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study. | Surg Endosc | 2023 | https://conductscience.org/library/papers/37700013 | PubMed |
| 17 | 27222552 | Bariatric Surgery in Obese Patients With Type 1 Diabetes. | Diabetes Care | 2016 | https://conductscience.org/library/papers/27222552 | PubMed |
| 18 | 38423026 | 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. | Lancet Diabetes Endocrinol | 2024 | https://conductscience.org/library/papers/38423026 | PubMed |
| 19 | 34435943 | Culturally tailored lifestyle interventions for the prevention and management of type 2 diabetes in adults of Black African ancestry: a systematic review of tailoring methods and their effectiveness. | Public Health Nutr | 2022 | https://conductscience.org/library/papers/34435943 | PubMed |
| 20 | 38887616 | Effects of combined aerobic and resistance training on glycemic control, blood pressure, inflammation, cardiorespiratory fitness and quality of life in patients with type 2 diabetes and overweight/obesity: a systematic review and meta-analysis. | PeerJ | 2024 | https://conductscience.org/library/papers/38887616 | PubMed |
Cited by50
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985198 | Biomarkers for the diagnosis and management of cardiovascular-kidney-metabolic syndrome: recent advances and prospects for clinical application. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42985198 | PubMed |
| 42979537 | Balancing clinical benefits and behavioral risks of obesity-focused management in youth-onset type 2 diabetes: A narrative review. | touchREV Endocrinol | 2026 | https://conductscience.org/library/papers/42979537 | PubMed |
| 42977939 | Impact of co-administration of proton pump inhibitors on efficacy and safety of oral semaglutide in patients with type 2 diabetes: a single-center retrospective study. | J Pharm Health Care Sci | 2026 | https://conductscience.org/library/papers/42977939 | PubMed |
| 42943269 | Combination Therapy Potential of HTD1801 (Berberine Ursodeoxycholate) in MASLD/MASH and Cardiovascular-Kidney-Metabolic Disease: A Narrative Review. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943269 | PubMed |
| 42942356 | Associations of TNF-α, Uric Acid, and the Leptin/Adiponectin Ratio with HOMA-IR in Hospitalized Adults: A Cross-Sectional Secondary Analysis of 147 Patients. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42942356 | PubMed |
| 42941244 | ARF6: Biomarker, Therapeutic Target, and AI-Driven Precision Management for Type 2 Diabetes with Obesity. | Metabolites | 2026 | https://conductscience.org/library/papers/42941244 | PubMed |
| 42898214 | Determinants of variable response to GLP-1 receptor agonists: A mechanism-informed framework for precision treatment of obesity. | Obes Pillars | 2026 | https://conductscience.org/library/papers/42898214 | PubMed |
| 42891248 | Social Determinants of Health and Behavioral Risk Factors in the Tuberculosis-Type 2 Diabetes Syndemic: A Narrative Review. | Cureus | 2026 | https://conductscience.org/library/papers/42891248 | PubMed |
| 42890326 | Initiation of Glucagon-Like Peptide-1 Receptor Agonist Therapy and Lifestyle Modifications for Morbid Obesity in a Patient With Paroxysmal Atrial Fibrillation, Severe Osteoarthritis, and Obstructive Sleep Apnea: A Case Report. | Cureus | 2026 | https://conductscience.org/library/papers/42890326 | PubMed |
| 42889937 | Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity. | Diabetes Obes Cardiometab CARE | 2026 | https://conductscience.org/library/papers/42889937 | PubMed |
| 42851902 | Beyond efficacy: the treatment lifecycle of incretin and multi-receptor agonists. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42851902 | PubMed |
| 42851870 | Patient Knowledge of GLP-1 Receptor Agonists for Obesity and Exploration of Potential Household-Level Effects in an Urban Health System. | Obes Sci Pract | 2026 | https://conductscience.org/library/papers/42851870 | PubMed |
| 42827785 | Clinical and metabolic links between hypothyroidism and metabolic syndrome: a review. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42827785 | PubMed |
| 42824721 | Association between diet quality and overweight or obesity among adults with type 2 diabetes at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia. | Obes Pillars | 2026 | https://conductscience.org/library/papers/42824721 | PubMed |
| 42802782 | Associations Between Body Mass Index Trajectories and Healthcare Utilization and Costs Among Patients with Type 2 Diabetes in Finland. | Clin Epidemiol | 2026 | https://conductscience.org/library/papers/42802782 | PubMed |
| 42741141 | Comparative change in HbA1c and weight outcomes between obese and non-obese adults with type 2 diabetes mellitus treated with SGLT-2 inhibitors or GLP-1 receptor agonists. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42741141 | PubMed |
| 42736522 | Real-World Evidence for Existing Anti-Obesity Therapies-The Realities of Treatment Adherence, Tolerability, Access and Patient Satisfaction. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42736522 | PubMed |
| 42707139 | Prevalence, associated clinical factors, and genetic characteristics of endocrinopathies in common variable immunodeficiency: a retrospective study of 95 adult patients from a single tertiary care center. | Front Immunol | 2026 | https://conductscience.org/library/papers/42707139 | PubMed |
| 42694689 | Exercise and physical activity interventions in type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42694689 | PubMed |
| 42681751 | Incretin-Based Therapies as Cardiometabolic Interventions: Outcome Hierarchy, Receptor-Network Pharmacology and Phenotype-Based Clinical Positioning. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42681751 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41358882
GET https://conductscience.org/api/papers/v1/41358882/references?page=2